Adrienne M Dorrance

Title: Adrienne M Dorrance: Innovator in Biomedical Research

Introduction

Adrienne M Dorrance is an accomplished inventor based in Columbus, OH. With a focus on developing groundbreaking biomedical solutions, she has made significant contributions through her innovative work and research.

Latest Patents

Adrienne is credited with two notable patents. Her latest inventions include "Recombinant EGFL7, EGFL7 antibodies, and uses thereof," which relates to the development of recombinant EGFL7 and its associated antibodies. This patent outlines their applications in various therapeutic contexts. The second patent, "Antisense oligomers targeting HOXB-AS3 long non-coding RNA," addresses methods of treating acute myeloid leukemia by targeting the long non-coding RNA HOXB-AS3.

Career Highlights

Adrienne's career has been marked by her affiliations with reputable institutions. She has worked with the Ohio State Innovation Foundation, where she contributed to advancing research and innovation. Additionally, her time at Aalborg University further underscores her dedication to scientific inquiry and development.

Collaborations

Throughout her career, Adrienne has collaborated with notable professionals, including Ramiro Garzon and Dimitrios Papaioannou. These partnerships have undoubtedly enriched her research endeavors and contributed to the success of her inventions.

Conclusion

Adrienne M Dorrance exemplifies the spirit of innovation in the biomedical field. Through her patents and collaborations, she continues to pave the way for advancements that hold the potential to improve medical treatments and patient outcomes.